Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Prescription Dermatological Drugs Market Report 2025

Prescription Dermatological Drugs Global Market Report 2025 - By Drug Class (Corticosteroids, Retinoids, Calcineurin Inhibitors, Antifungal Agents, Antibiotics, Other Drug Classes), By Indication (Acne, Psoriasis, Dermatitis, Fungal Skin Infections, Other Indications ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Prescription Dermatological Drugs Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Prescription Dermatological Drugs Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Prescription Dermatological Drugs Market

Prescription dermatological drugs refer to medications that are prescribed by healthcare providers to treat various skin conditions. They are used for managing issues such as acne, eczema, psoriasis, and other dermatological disorders, often containing active ingredients that require medical supervision.

The main drug classes of prescription dermatological drugs are corticosteroids, retinoids, calcineurin inhibitors, antifungal agents, antibiotics, and others. Corticosteroids, a class of steroid hormones derived from the adrenal cortex or their synthetic analogs, are mainly used to alleviate inflammation and suppress immune responses in several medical conditions. These drugs are commonly prescribed for indications such as acne, psoriasis, dermatitis, fungal skin infections, and others and are distributed through several channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others.

How Is The Prescription Dermatological Drugs Market Segmented?

The prescription dermatological drugs market covered in this report is segmented –

1) By Drug Class: Corticosteroids, Retinoids, Calcineurin Inhibitors, Antifungal Agents, Antibiotics, Other Drug Classes

2) By Indication: Acne, Psoriasis, Dermatitis, Fungal Skin Infections, Other Indications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids

2) By Retinoids: Topical Retinoids, Oral Retinoids

3) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors, Oral Calcineurin Inhibitors

4) By Antifungal Agents: Topical Antifungals, Oral Antifungals

5) By Antibiotics: Topical Antibiotics, Oral Antibiotics

6) By Other Drug Classes: Immunosuppressants, Phototherapy Agents

Prescription Dermatological Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Prescription Dermatological Drugs Market Size 2025 And Growth Rate?

The prescription dermatological drugs market size has grown strongly in recent years. It will grow from $37.77 billion in 2024 to $40.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the rise in the prevalence of skin disorders, increase in awareness of skin health, growth in dermatology clinics, expanding geriatric population, rise in healthcare spending, and rise in R&D investments.

What Is The Prescription Dermatological Drugs Market Growth Forecast?

The prescription dermatological drugs market size is expected to see strong growth in the next few years. It will grow to $52.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing prevalence of skin disorders, rising awareness of dermatological health, expanding telemedicine adoption for dermatology consultations, growing skin care aesthetics, enhanced insurance coverage for dermatological treatments, and increasing demand for personalized medicine and precision dermatology. Major trends in the forecast period include the development of targeted biologic therapies, the adoption of gene editing for skin conditions, advancements in drug delivery systems, the adoption of personalized treatments through genetic profiling, the adoption of topical medications with improved absorption, and the adoption of artificial intelligence to optimize drug formulations and treatment plans.

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Prescription Dermatological Drugs Market: Rising Prevalence Of Skin Conditions Boosts Demand For Prescription Treatments

The increasing prevalence of dermatological conditions is expected to drive the growth of the prescription dermatological drugs market going forward. Dermatological conditions are disorders of the skin, hair, or nails, including eczema, psoriasis, and acne, which require medical treatment to manage symptoms effectively. The increasing prevalence of dermatological conditions is primarily due to the growing exposure to environmental pollutants, lifestyle changes, and rising stress levels. Prescription dermatological drugs play a crucial role in managing dermatological conditions by offering targeted treatments to alleviate symptoms and improve long-term skin health. For instance, in March 2022, Europe PubMed Central, a UK-based organization hosted by EMBL’s European Bioinformatics Institute for biomedical research works, reported that, in a study conducted across 27 European countries, approximately 43.35% of participants, equating to around 185 million individuals, experienced at least one skin condition, with fungal infections, atopic dermatitis, and acne being the most common. Therefore, the increasing prevalence of dermatological conditions is driving the growth of the prescription dermatological drugs market.

Who Are The Major Players In The Global Prescription Dermatological Drugs Market?

Major companies operating in the prescription dermatological drugs market are Pfizer Inc., Johnson & Johnson, Merck KGaA, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Mylan NV, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Health Care Limited, Leo Pharma A/S, Glenmark Pharmaceuticals Limited, Almirall S.A., DermBiont Inc.

What Are The Key Trends Of The Global Prescription Dermatological Drugs Market: Strategic Collaborations Driving Innovations In Dermatological Treatments

Major companies operating in the prescription dermatological drugs market are focusing on developing innovative treatments, such as prurigo nodularis, to address unmet medical needs and offer more effective solutions for patients suffering from chronic and challenging skin conditions. Prurigo nodularis is a chronic skin condition characterized by the presence of intensely itchy, raised, and firm nodules or bumps on the skin. For instance, in September 2022, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, partnered with Sanofi S.A., a France-based pharmaceutical company, and received approval from the U.S. Food and Drug Administration (FDA) for Dupixent (dupilumab). This marks the first and only FDA-approved treatment for prurigo nodularis, a chronic skin condition characterized by intensely itchy nodules. The approval was granted based on clinical trials showing significant improvements in itch severity and skin lesions in patients treated with Dupixent compared to those receiving a placebo.

What Are Latest Mergers And Acquisitions In The Prescription Dermatological Drugs Market: Organon Strengthens Dermatology Portfolio With Dermavant Acquisition

In October 2024, Organon & Co., a US-based pharmaceutical company, acquired Dermavant Sciences Ltd. for an amount of $1.2 billion. With this acquisition, Organon aims to enhance its dermatology portfolio by expanding its range of innovative treatments for chronic skin conditions, including prurigo nodularis and psoriasis. Dermavant Sciences Ltd. is a US-based company that specializes in developing therapeutic solutions in immunodermatology.

What Is The Regional Outlook For The Global Prescription Dermatological Drugs Market?

North America was the largest region in the prescription dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription dermatological drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the prescription dermatological drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prescription Dermatological Drugs  Market?

The prescription dermatological drugs market consists of sales of products such as antifungals, antihistamines, and isotretinoin. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Prescription Dermatological Drugs  Industry?

The prescription dermatological drugs market research report is one of a series of new reports from The Business Research Company that provides prescription dermatological drugs market statistics, including the prescription dermatological drugs industry's global market size, regional shares, competitors with a prescription dermatological drugs market share, detailed prescription dermatological drugs market segments, market trends and opportunities, and any further data you may need to thrive in the prescription dermatological drugs industry. This prescription dermatological drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Prescription Dermatological Drugs Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $40.38 billion
Revenue Forecast In 2034 $52.27 billion
Growth Rate CAGR of 6.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The prescription dermatological drugs market covered in this report is segmented –
1) By Drug Class: Corticosteroids, Retinoids, Calcineurin Inhibitors, Antifungal Agents, Antibiotics, Other Drug Classes
2) By Indication: Acne, Psoriasis, Dermatitis, Fungal Skin Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Retinoids: Topical Retinoids, Oral Retinoids
3) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors, Oral Calcineurin Inhibitors
4) By Antifungal Agents: Topical Antifungals, Oral Antifungals
5) By Antibiotics: Topical Antibiotics, Oral Antibiotics
6) By Other Drug Classes: Immunosuppressants, Phototherapy Agents
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Merck KGaA, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Mylan NV, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Health Care Limited, Leo Pharma A/S, Glenmark Pharmaceuticals Limited, Almirall S.A., DermBiont Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Prescription Dermatological Drugs Market Characteristics

    3. Prescription Dermatological Drugs Market Trends And Strategies

    4. Prescription Dermatological Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Prescription Dermatological Drugs Growth Analysis And Strategic Analysis Framework

    5.1. Global Prescription Dermatological Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Prescription Dermatological Drugs Market Growth Rate Analysis

    5.4. Global Prescription Dermatological Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Prescription Dermatological Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Prescription Dermatological Drugs Total Addressable Market (TAM)

    6. Prescription Dermatological Drugs Market Segmentation

    6.1. Global Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Corticosteroids

    Retinoids

    Calcineurin Inhibitors

    Antifungal Agents

    Antibiotics

    Other Drug Classes

    6.2. Global Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Acne

    Psoriasis

    Dermatitis

    Fungal Skin Infections

    Other Indications

    6.3. Global Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    Other Distribution Channels

    6.4. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Topical Corticosteroids

    Oral Corticosteroids

    Injectable Corticosteroids

    6.5. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Retinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Topical Retinoids

    Oral Retinoids

    6.6. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Topical Calcineurin Inhibitors

    Oral Calcineurin Inhibitors

    6.7. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Antifungal Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Topical Antifungals

    Oral Antifungals

    6.8. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Topical Antibiotics

    Oral Antibiotics

    6.9. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunosuppressants

    Phototherapy Agents

    7. Prescription Dermatological Drugs Market Regional And Country Analysis

    7.1. Global Prescription Dermatological Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Prescription Dermatological Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Prescription Dermatological Drugs Market

    8.1. Asia-Pacific Prescription Dermatological Drugs Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Prescription Dermatological Drugs Market

    9.1. China Prescription Dermatological Drugs Market Overview

    9.2. China Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Prescription Dermatological Drugs Market

    10.1. India Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Prescription Dermatological Drugs Market

    11.1. Japan Prescription Dermatological Drugs Market Overview

    11.2. Japan Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Prescription Dermatological Drugs Market

    12.1. Australia Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Prescription Dermatological Drugs Market

    13.1. Indonesia Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Prescription Dermatological Drugs Market

    14.1. South Korea Prescription Dermatological Drugs Market Overview

    14.2. South Korea Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Prescription Dermatological Drugs Market

    15.1. Western Europe Prescription Dermatological Drugs Market Overview

    15.2. Western Europe Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Prescription Dermatological Drugs Market

    16.1. UK Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Prescription Dermatological Drugs Market

    17.1. Germany Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Prescription Dermatological Drugs Market

    18.1. France Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Prescription Dermatological Drugs Market

    19.1. Italy Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Prescription Dermatological Drugs Market

    20.1. Spain Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Prescription Dermatological Drugs Market

    21.1. Eastern Europe Prescription Dermatological Drugs Market Overview

    21.2. Eastern Europe Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Prescription Dermatological Drugs Market

    22.1. Russia Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Prescription Dermatological Drugs Market

    23.1. North America Prescription Dermatological Drugs Market Overview

    23.2. North America Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Prescription Dermatological Drugs Market

    24.1. USA Prescription Dermatological Drugs Market Overview

    24.2. USA Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Prescription Dermatological Drugs Market

    25.1. Canada Prescription Dermatological Drugs Market Overview

    25.2. Canada Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Prescription Dermatological Drugs Market

    26.1. South America Prescription Dermatological Drugs Market Overview

    26.2. South America Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Prescription Dermatological Drugs Market

    27.1. Brazil Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Prescription Dermatological Drugs Market

    28.1. Middle East Prescription Dermatological Drugs Market Overview

    28.2. Middle East Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Prescription Dermatological Drugs Market

    29.1. Africa Prescription Dermatological Drugs Market Overview

    29.2. Africa Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Prescription Dermatological Drugs Market Competitive Landscape And Company Profiles

    30.1. Prescription Dermatological Drugs Market Competitive Landscape

    30.2. Prescription Dermatological Drugs Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    31. Prescription Dermatological Drugs Market Other Major And Innovative Companies

    31.1. Novartis AG

    31.2. GSK plc

    31.3. Amgen Inc.

    31.4. Teva Pharmaceutical Industries Ltd.

    31.5. Intas Pharmaceuticals Inc.

    31.6. Regeneron Pharmaceuticals Inc.

    31.7. Mylan NV

    31.8. Sun Pharmaceutical Industries Ltd.

    31.9. Cipla Limited

    31.10. Dr. Reddy's Laboratories Ltd.

    31.11. Zydus Cadila Health Care Limited

    31.12. Leo Pharma A/S

    31.13. Glenmark Pharmaceuticals Limited

    31.14. Almirall S.A.

    31.15. DermBiont Inc.

    32. Global Prescription Dermatological Drugs Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Prescription Dermatological Drugs Market

    34. Recent Developments In The Prescription Dermatological Drugs Market

    35. Prescription Dermatological Drugs Market High Potential Countries, Segments and Strategies

    35.1 Prescription Dermatological Drugs Market In 2029 - Countries Offering Most New Opportunities

    35.2 Prescription Dermatological Drugs Market In 2029 - Segments Offering Most New Opportunities

    35.3 Prescription Dermatological Drugs Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Retinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Antifungal Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Prescription Dermatological Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Prescription Dermatological Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Johnson & Johnson Financial Performance
  • Table 82: Merck KGaA Financial Performance
  • Table 83: AbbVie Inc. Financial Performance
  • Table 84: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Retinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Antifungal Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Prescription Dermatological Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Prescription Dermatological Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Johnson & Johnson Financial Performance
  • Figure 82: Merck KGaA Financial Performance
  • Figure 83: AbbVie Inc. Financial Performance
  • Figure 84: Bayer AG Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Read More

Dermatology Diagnostic Devices Global Market Report 2024 – By Type (Dermatoscopes, Imaging Equipment, Microscopes And Trichoscopes, Biopsy Devices, Other Types), By Application ( Dermatitis, Psoriasis, Skin Cancer, Lesion, Cellulitis, Other Applications), By End-Users (Dermatology Centers, Hospitals, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Dermatology Medical Lasers Global Market Report 2025 – By Device (Surgical Lasers, Vascular Lasers), By Application (Cancer, Hair Removal, Tattoo Removal, Resurfacing, Other Applications), By End-users (Hospitals, Skin Care Clinics, Cosmetic Surgical Centres) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dermatology Devices Global Market Report 2025 – By Product Type (Diagnostic Devices, Treatment Devices, Other Product Types), By Application (Skin Cancer Diagnosis, Psoriasis, Skin Rejuvenation, Warts, Other Applications, By End User (Hospitals (Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Dermatology Drugs Global Market Report 2025 – By Product Type( Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs), By Animal Type( Companion Animal, Livestock Animal), By Drug Indication( Parasitic Infections, Allergic Infections, Other Indications), By Route of Administration( Topical, Injectable, Oral), By Distribution Channel( Retail, Hospital Pharmacies, Online) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Online Dermatology Consultation Global Market Report 2025 – By Modality (Store-And-Forward (Asynchronous), Real-Time (Synchronous), Other Types), By Application (Skin Care, Hair Loss, Sign of Aging, Other Applications), By End-User (Healthcare Facilities, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dermatology Endoscopy Devices Global Market Report 2025 – By Type (Traditional Or Analogue Dermatoscopes, Digital Dermatoscopes), By Product (Polarized, Non-Polarized, Hybrid), By Light Source (LED (Light Emitting Diode), Halogen, Xenon, UV (Ultraviolet)), By Modality (Handheld, Headband, Trolley-Mounted), By Application (Skin Cancer, Warts, Scabies, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dermatology Lasers Global Market Report 2025 – By Type (Gas Laser Machine, Semiconductor Laser Machine, Gem Laser Machine, Other Types), By Technology (Ablative Dermatology Lasers, Non-Ablative Dermatology Lasers), By Application (Therapeutic, Aesthetic, Other Applications), By End Users (Hospitals, Skin Care Clinics, Cosmetic Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dermatology OTC Medications Global Market Report 2025 – By Type (Tablets And Capsules, Oils Gels, Creams And Ointments, Other Types), By Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-Fungal, Wart Remover, Other Indications), By Route Of Administration (Topical, Oral), By Distribution Channel (Online Distribution, Offline Distribution) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Prescription Dermatological Drugs market?

Prescription dermatological drugs refer to medications that are prescribed by healthcare providers to treat various skin conditions. They are used for managing issues such as acne, eczema, psoriasis, and other dermatological disorders, often containing active ingredients that require medical supervision. For further insights on the Prescription Dermatological Drugs market, request a sample here

How will the Prescription Dermatological Drugs market drivers and restraints affect the market dynamics? What forces will shape the Prescription Dermatological Drugs industry going forward?

The Prescription Dermatological Drugs market major growth driver - Rising Prevalence Of Skin Conditions Boosts Demand For Prescription Treatments. For further insights on the Prescription Dermatological Drugs market, request a sample here

What is the forecast market size or the forecast market value of the Prescription Dermatological Drugs market?

The Prescription Dermatological Drugs market size has grown strongly in recent years. The prescription dermatological drugs market size has grown strongly in recent years. It will grow from $37.77 billion in 2024 to $40.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the rise in the prevalence of skin disorders, increase in awareness of skin health, growth in dermatology clinics, expanding geriatric population, rise in healthcare spending, and rise in R&D investments. The prescription dermatological drugs market size is expected to see strong growth in the next few years. It will grow to $52.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing prevalence of skin disorders, rising awareness of dermatological health, expanding telemedicine adoption for dermatology consultations, growing skin care aesthetics, enhanced insurance coverage for dermatological treatments, and increasing demand for personalized medicine and precision dermatology. Major trends in the forecast period include the development of targeted biologic therapies, the adoption of gene editing for skin conditions, advancements in drug delivery systems, the adoption of personalized treatments through genetic profiling, the adoption of topical medications with improved absorption, and the adoption of artificial intelligence to optimize drug formulations and treatment plans. For further insights on the Prescription Dermatological Drugs market, request a sample here

How is the Prescription Dermatological Drugs market segmented?

The prescription dermatological drugs market covered in this report is segmented –
1) By Drug Class: Corticosteroids, Retinoids, Calcineurin Inhibitors, Antifungal Agents, Antibiotics, Other Drug Classes
2) By Indication: Acne, Psoriasis, Dermatitis, Fungal Skin Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Retinoids: Topical Retinoids, Oral Retinoids
3) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors, Oral Calcineurin Inhibitors
4) By Antifungal Agents: Topical Antifungals, Oral Antifungals
5) By Antibiotics: Topical Antibiotics, Oral Antibiotics
6) By Other Drug Classes: Immunosuppressants, Phototherapy Agents For further insights on the Prescription Dermatological Drugs market, request a sample here

Which region has the largest share of the Prescription Dermatological Drugs market? What are the other regions covered in the report?

North America was the largest region in the prescription dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription dermatological drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Prescription Dermatological Drugs market, request a sample here.

Who are the major players in the Prescription Dermatological Drugs market?

Major companies operating in the prescription dermatological drugs market are Pfizer Inc., Johnson & Johnson, Merck KGaA, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Mylan NV, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Health Care Limited, Leo Pharma A/S, Glenmark Pharmaceuticals Limited, Almirall S.A., DermBiont Inc. . For further insights on the Prescription Dermatological Drugs market, request a sample here.

What are the key trends in the Prescription Dermatological Drugs market?

Major trends in the Prescription Dermatological Drugs market include Strategic Collaborations Driving Innovations In Dermatological Treatments. For further insights on the Prescription Dermatological Drugs market, request a sample here.

What are the major opportunities in the Prescription Dermatological Drugs market? What are the strategies for the Prescription Dermatological Drugs market?

For detailed insights on the major opportunities and strategies in the Prescription Dermatological Drugs market, request a sample here.

How does the Prescription Dermatological Drugs market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Prescription Dermatological Drugs market growth and SWOT analysis of the Prescription Dermatological Drugs industry, request a sample here.

For detailed insights on Prescription Dermatological Drugs's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Prescription Dermatological Drugs industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Prescription Dermatological Drugs industry,

What are the key dynamics influencing the Prescription Dermatological Drugs market growth? SWOT analysis of the Prescription Dermatological Drugs market. request a sample here.